Round Rock Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Round Rock Advisors's NEO Position: Q3 2026 in Review
Round Rock Advisors increased its NeoGenomics (NEO) stake by 0.13% in Q3 2026, buying an estimated $677 and bringing the position to 31,498 shares worth $578K. The position accounts for 0.08% of the portfolio, ranked #178.
Round Rock Advisors first reported a position in NEO in Q1 2026 and has held it in 3 quarters since. 297 funds tracked by Wall St. Rank hold NEO as of Q3 2026.
- Round Rock Advisors held 31,498 shares of NeoGenomics worth $578K as of Q3 2026.
- Round Rock Advisors bought 41 NeoGenomics shares in Q3 2026, an estimated $677.
- NeoGenomics made up 0.08% of Round Rock Advisors's portfolio in Q3 2026, its #178 holding.
- Round Rock Advisors first reported a position in NeoGenomics in Q1 2026 and has held it in 3 quarters since.
- 297 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.
Based on Round Rock Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.